Gregory J. Divis - 10 Aug 2023 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role: Chief Executive Officer, Director
Signature: /s/ Jerad G. Seurer, Attorney-in-Fact
Issuer symbol: AVDL
Transactions as of: 10 Aug 2023
Transactions value $: $131,997
Form type: 4
Filing time: 10 Aug 2023, 18:45:18 UTC
Previous filing: 05 Jun 2023
Next filing: 04 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVDL	ADSs	Purchase	$132K	+10K	+6.71%	$13.20	159K	10 Aug 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.86 to $13.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.86 to $13.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.